Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 532.12 million compared to INR 469.46 million a year ago. Revenue was INR 560.97 million compared to INR 487.58 million a year ago. Net income was INR 86.8 million compared to INR 28.84 million a year ago. Basic earnings per share from continuing operations was INR 0.489 compared to INR 0.179 a year ago. Diluted earnings per share from continuing operations was INR 0.489 compared to INR 0.179 a year ago.